VacZine Analytics  
ExpertREACT - PREMIUM

Healthcare acquired infections and vaccines - the profile determines everything. Published 28th April 2010

Healthcare acquired infections (HAIs) continue to be a major concern to all hospital stakeholders. Beyond increased infection control and stewardship of antibiotic use, the vaccine industry is taking the possibility of further interventions seriously with major programs now in advanced clinical development. VacZine Analytics has analyzed the commercial viability of new "nosocomial vaccines" and discuss the latest issues.

PAGES: 2

PREMIUMThis article is available only on a "pay per view" basis or to purchasers of MarketVIEW: Staphylococcus aureus or Pseudomonas aureginosa vaccines (CAT Nos: VAMV002 & VAMV010)

CAT No: CONTENTS: PRICE*: PURCHASE:
VAER100428 Click here>> USD $19.99 GBP 12.99
*Prices quotes are global use and distribution. For UK orders VAT will be added at 17.5%.

Return to main list>> Questions about this article?






© 2010 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains